{
  "docId": "019dd923-622c-750b-8b99-bca3fd68622d",
  "docSlug": "4c8fe6013c68",
  "documentTitle": "iRhythm Technologies, Inc. (IRTC)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-18 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 36,
  "pageCount": 101,
  "prevPage": 35,
  "nextPage": 37,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "Uses a direct quote from an earnings call to frame a 'new news' event as a material threat.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "callout_box",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-bca3fd68622d/36",
  "deckHref": "/decks/019dd923-622c-750b-8b99-bca3fd68622d",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-bca3fd68622d.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-bca3fd68622d#slide-36",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.96,
        "x": 0.02,
        "y": 0.81
      },
      "kind": "callout",
      "text": "We believe CEO Blackford just informed investors that the Company's widely assumed easiest source of growth, increasing share in the existing MCT market, holds at least 20% less potential than previously believed.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c221269f-4181-460a-8767-c46f8e727a99",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "We believe CEO Blackford just informed investors that the Company's widely assumed easiest source of growth, increasing share in the existing MCT market, holds at least 20% less potential than previously believed.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-0395-748f-9566-cd055863c439",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.4,
        "x": 0.02,
        "y": 0.96
      },
      "kind": "other",
      "text": "Source: iRhythm Q2 2025 earnings call transcript, Spruce Point research",
      "attrs": null,
      "subkind": "source-note",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7587cbc1-c696-468e-bcb4-e4779b52e300",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.96,
        "x": 0.02,
        "y": 0.17
      },
      "kind": "paragraph",
      "text": "We believe iRhythm management has touted the MCT opportunity for years without clearly acknowledging the risks and addressable market limitations presented by insourced data analysis...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e8e83e1b-e46b-41f0-a6c3-e9046fa16f71",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.73,
        "x": 0.25,
        "y": 0.51
      },
      "kind": "quote",
      "text": "But I also think as we learn more about the AT -- or sorry, the MCT market, there's probably 2 markets within MCT... They're doing the interpretation, the reading right there in clinic... I think that's probably 20% or so of the entire MCT market...",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f8e8fe1f-f93d-4a64-91a6-daabd1712a63",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "But I also think as we learn more about the AT -- or sorry, the MCT market, there's probably 2 markets within MCT. There's what we call sort of the buy and build market where customer accounts are buying the device directly from competitor of ours. They put it in their clinic. They're doing the interpretation, the reading right there in clinic, downloading the data. We don't offer that sort of business model. And Zio MCT is something that we're going to have to continue to evaluate how we address that segment of the market. I think that's probably 20% or so of the entire MCT market that we're still probably going to have to think through the right product market fit for how we get after that segment of the market. But there's still 80% of that MCT market that our MCT product, new MCT product is going to go squarely at and I think going to have tremendous success within it. — iRhythm CEO Blackford on Q2 2025 Earnings Call, 7/31/25",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-0395-748f-9566-d23c83523534",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.65,
        "x": 0.31,
        "y": 0.03
      },
      "kind": "title",
      "text": "We Believe iRhythm Acknowledged The Issue Of Data Analysis Insourcing For The First Time On Its Q2 Call",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f7c9926f-a0eb-40c4-83e5-24cebd652bf4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.96,
        "x": 0.02,
        "y": 0.44
      },
      "kind": "title",
      "text": "CEO Blackford Finally Acknowledges Negative MCT Market Dynamics Related to Insourcing",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "880461cd-91f7-46db-882c-4deb0d03ff1b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "ceo-quote-contradiction",
      "slug": null,
      "matchId": "3450fcf6-e0f1-4672-97a7-1507cf2bdcfb",
      "evidence": "Contrasts historical management claims with a specific quote from the Q2 earnings call.",
      "confidence": 0.95
    }
  ],
  "arcBeats": [
    {
      "to": 40,
      "from": 25,
      "beatId": "0a38a245-fa4d-49e4-b7bb-ca7320e46cc1",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Thesis Headline",
      "beatSlug": null,
      "evidence": "The document presents Spruce Point Capital Management's thesis and key messages.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}